FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2014/10/005135 [Registered on: 22/10/2014] Trial Registered Retrospectively
Last Modified On: 20/10/2014
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Preventive 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   comparison of daily and weekly iron effect during pregnancy 
Scientific Title of Study   Estimation of oxidative stress in pregnant women on daily versus weekly iron supplementation (An ICMR Task Force Study) 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
5/7/165/06-RHN  Other 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Neeta Kumar 
Designation  Scientist C 
Affiliation  ICMR 
Address  Div. Of RCH, Room 214, first floor, ICMR, New Delhi
E-62 Ansari nagar, east campus, AIIMS, New Delhi
New Delhi
DELHI
110029
India 
Phone  9313195247  
Fax  01126588755  
Email  neeta@icmr.org.in  
 
Details of Contact Person
Scientific Query
 
Name  Dr Neeta Kumar 
Designation  Scientist C 
Affiliation  ICMR 
Address  Div. Of RCH, Room 214, first floor, ICMR, New Delhi
E-62 Ansari nagar, east campus, AIIMS, New Delhi
New Delhi
DELHI
110029
India 
Phone  9313195247  
Fax  01126588755  
Email  neeta@icmr.org.in  
 
Details of Contact Person
Public Query
 
Name  Dr Neeta Kumar 
Designation  Scientist C 
Affiliation  ICMR 
Address  Div. Of RCH, Room 214, first floor, ICMR, New Delhi
E-62 Ansari nagar, east campus, AIIMS, New Delhi
New Delhi
DELHI
110029
India 
Phone  9313195247  
Fax  01126588755  
Email  neeta@icmr.org.in  
 
Source of Monetary or Material Support  
Indian council of Medical Research, New delhi 
 
Primary Sponsor  
Name  Indian Council of Medical Research 
Address  Ansari nagar, new Delhi-29 
Type of Sponsor  Government funding agency 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Suneeta Mittal  HRRC AIIMS  HRRC AIIMS, Department of Obs and gyne, AIIMS, New Delhi-110029
New Delhi
DELHI 
9313195247
01126588755
suneeta_mittal@yahoo.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
AIIMS Instituional ethical review board  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  pregnancy and oral iron in daily versus weekly dose 
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  100 mg iron folic acid tabs daily   Daily dose of 100 mg iron folic acid tablet starting from 13-16 weeks of pregnancy till 6 weeks post partum as per recommendation of National anemia control program 
Intervention  200 mg iron and folic acid tablet once weekly  200 mg iron and folic acid tablet weekly dose till 6 weeks postpartum. 
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  30.00 Year(s)
Gender  Female 
Details  Age 20-30 years
Hemoglobin is above 11 gm/dl
Middle socio-economic income group
 
 
ExclusionCriteria 
Details  History of chronic ailment
Taking any iron preparation already at the time of enrollment. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant, Investigator, Outcome Assessor and Date-entry Operator Blinded 
Primary Outcome  
Outcome  TimePoints 
oxidative stress status in plasma of pregnant women taking oral iron in daily versus weekly doses for anemia prevention  At three point of time tests were conducted. Oxidative stress, micro nutrient and diet were assessed at the time of enrollment 14-16 weeks of primi pregnancy, after 3 months of supplementation and third time at 6 weeks post delivery 
 
Secondary Outcome  
Outcome  TimePoints 
effect of pregnancy on oxidative stress, relationship of oxidative stress with birth outcome and effect of daily versus weekly iron on side effects, acceptability and mode of delivery  At 3 point of time, blood samples and information were sought from study participants, at baseline (14-16 weeks pregnancy, thirst trimester, 6 weeks post delivery 
 
Target Sample Size   Total Sample Size="650"
Sample Size from India="650" 
Final Enrollment numbers achieved (Total)= ""
Final Enrollment numbers achieved (India)="" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   30/03/2009 
Date of Study Completion (India) Date Missing 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="3"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   none yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   This  randomized controlled clinical trial at a tertiary level hospital, recruited primi para  women in 2 phases in their first trimester and supplemented oral iron in two schedules. One is 100 mg elemental iron daily and another is 200 mg elemental iron weekly. Detailed dietary history, oxidative stress parameters and micro-nutrients were tested to estimate the oxidative stress in normal pregnant women while supplementing iron in daily and weekly doses. After completion of 650 enrollments, data is under analysis for effect on total and subgroups, both ways. 
Close